Search results
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 23 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
Moderna announces positive Phase III data for Covid-19/Influenza mRNA vaccine
Clinical Trials Arena via Yahoo Finance· 4 days agoAt this time, mRNA...first mRNA influenza vaccine on the market. Moderna reported that a single dose...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 6 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
Moderna's COVID-flu combo shot outperformed existing vaccines in a late-stage trial
Quartz· 6 days agoS. Food and Drug Administration (FDA) in May approved Moderna’s mRNA-based respiratory syncytial...
Moderna Announces Good Results From Trial of Combo COVID/Flu Vaccine | FOX 28 Spokane
FOX 28 Spokane· 6 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Moderna's combo Covid, flu vaccine meets goals in late-stage study - Boston Business Journal
The Business Journals· 6 days agoModerna Inc. is making steady headway on its plan to launch all four products from its respiratory ...
A new Alzheimer's drug, combined COVID and flu vaccine update, and salmonella concerns. 3 health...
Yahoo Life Style via AOL· 15 hours agoAdditionally, the study's protocol for stopping treatment when amyloid levels (indicating...market...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 1 day agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
Moderna COVID/flu combo vaccine superior to separate shots in trial
Reuters via AOL· 6 days agoModerna said on Monday its combination vaccine to protect against both COVID-19 and influenza...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance via AOL· 5 days agoModerna president Stephen Hoge knows investors are waiting to see the company grow in a big way and...